Abstract
New engineered immune cells expressing two CARs directed against two different targets, polynucleotides for preparing said immune cells, pharmaceutical compositions comprising said immune cells, and the use of said immune cells in the treatment of cancers are provided herein.
Full Text
What is claimed is:
New engineered immune cells expressing two CARs directed against two different targets, polynucleotides for preparing said immune cells, pharmaceutical compositions comprising said immune cells, and the use of said immune cells in the treatment of cancers are provided herein.
Timeline
Filed
04/01/2026Published
07/23/2026Granted
Not AvailableIPC Codes(6)
C12N 5/0783:T cells; NK cells; Progenitors of T or NK cells
A61K 40/11:T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
A61K 40/31:Chimeric antigen receptors [CAR]